MacLean, D. B., Shi, H., Faessel, H. M., & Saad, F. (2015). Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males. J Clin Endocrinol Metab.
Chicago Style CitationMacLean, David B., Hongliang Shi, Hélène M. Faessel, i Fred Saad. "Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males." J Clin Endocrinol Metab 2015.
Cita MLAMacLean, David B., Hongliang Shi, Hélène M. Faessel, i Fred Saad. "Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males." J Clin Endocrinol Metab 2015.
Atenció: Aquestes cites poden no estar 100% correctes.